News & Analysis on Clinical Trial Services & Contract Research And Development
#TrialChat
The discussion surrounding clinical trial awareness has evolved “from mere conversations to action, creativity, and inclusivity from multiple stakeholders,” and will continue to evolve as we work together to create a paradigm shift in awareness, says...
The Wild Mouse gut microbiome licensed from the NIH will enable researchers to identify new host-microbe relationships, says Taconic Biosciences.
Since finalizing its risk-based monitoring guidance in 2013, the FDA is providing additional information in a new Q&A that reinforces the importance of performing risk assessments for all studies.
The Brazil-headquartered antibiotics company announces that it has invested in two new buildings, a few years after running into regulatory trouble due to non-compliance with cGMP.
US FTC rules that Endo used its dominant position in the market to delay competition from Impax with an illegal pay-for-delay deal for its Opana ER product.
TriNetX acquires Belgium-based Custodix NV to support industry partners looking to collaborate with non-US hospitals – becoming a “one-stop-shop” for clinical data, says SVP.